| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,813 | 9,225 | 13,195 | 19,851 | | Cost of Revenue | 6,884 | 7,406 | 8,545 | 12,214 | | | Gross Profit | 3,929 | 1,819 | 4,650 | 7,637 | | | Operating Expenses | | Research Development | 1,729 | 1,822 | 1,881 | 2,008 | | Selling General and Administrative | 3,664 | 3,625 | 4,099 | 4,477 | | Non Recurring |
-
| 25 | 1,032 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,464) | (3,653) | (2,362) | 1,152 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 210 | 160 | (1,572) | 526 | | Earnings Before Interest And Taxes | (1,197) | (3,493) | (3,934) | 1,678 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,197) | (3,493) | (3,934) | 1,678 | | Income Tax Expense | (384) | (1,625) | (1,218) | 587 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (813) | (1,868) | (2,716) | 1,091 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (813) | (1,868) | (2,716) | 1,091 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($813) | ($1,868) | ($2,716) | $1,091 |
|
0.60% Nasdaq 
Income Statement
